Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial-Reference-Cited by-同舟云学术

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Published:2015-03 Issue:3 Volume:16 Page:312-319
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cesne Axel Le,Blay Jean-Yves,Domont Julien,Tresch-Bruneel Emmanuelle,Chevreau Christine,Bertucci François,Delcambre Corinne,Saada-Bouzid Esma,Piperno-Neumann Sophie,Bay Jacques-Olivier,Mir Olivier,Ray-Coquard Isabelle,Ryckewaert Thomas,Valentin Thibaud,Isambert Nicolas,Italiano Antoine,Clisant Stéphanie,Penel Nicolas

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions;Mastrangelo;Cancer,2012

2. Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care;Sleijfer;Oncologist,2005

3. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial;Judson;Lancet Oncol,2014

4. International expert opinion on patient-tailored management of soft tissue sarcomas;Blay;Eur J Cancer,2014

5. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ann Oncol,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 24-kilogram retroperitoneal liposarcoma surgical management: A case report;Surgery Case Reports;2024-11

2. A Late-Arriving but Welcome Advance in Sarcoma Therapy;New England Journal of Medicine;2024-09-05

3. Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma;New England Journal of Medicine;2024-09-05

4. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms;Cancer Treatment Reviews;2024-04

5. Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study;PLOS ONE;2023-03-01